EUVIMEDEUVIMED entdecken
Crossref

Thymopentin (TP-5) prevents lipopolysaccharide-induced neuroinflammation and dopaminergic neuron injury by inhibiting the NF-κB/NLRP3 signaling pathway

Si-Jia Peng, Ya Feng, Xuan Li, Xi-Xi Wang, Yu Wang, Bu-Tian Zhou, Ye Liu, Te Liu, Yun-Cheng Wu

International Immunopharmacology · 2023-06 · 119 · 110109

DOI: 10.1016/j.intimp.2023.110109 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2023-06. Verfasst von Si-Jia Peng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, PR China. Hauptthemen laut MEDLINE: NF-kappa B, Signal Transduction, Thymopentin. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Ministry of Science and Technology of the People's Republic of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuroinflammation plays a pivotal role in neurodegenerative diseases, including Parkinson's disease, Alzheimer's disease, amyotrophic lateral sclerosis and stroke, and is accompanied by excessive release of inflammatory cytokines and mediators by activated microglia. Microglial inflammatory response inhibition may be an effective strategy for preventing inflammatory disorders. However, the reciprocal connections between the central nervous system (CNS) and immune system have not been elucidated. Thus far, these links have been proven to mainly involve immuno- and neuropeptides. The pentapeptide thymopentin (TP-5) exerts a significant immunomodulatory effect; however, its antineuroinflammatory effects and underlying mechanism are still unclear. In this study, lipopolysaccharide (LPS) was used to establish an inflammation model, and the therapeutic effect of TP-5 was evaluated. Behavioral tests showed that TP-5 treatment could improve the performance of LPS-treated mice in the open field and pole test, but not hanging wire test. TP-5 also attenuated neuronal lesions in the brains of LPS-treated mice. TP-5 reduced cytotoxicity and morphological changes in activated microglia. Label-free quantitative analysis indicated that the expression of multiple proteins and the activation of associated signaling pathways were altered by TP-5. Moreover, TP-5 could inhibit LPS-induced neuroinflammation in the brain and BV2 microglia and the expression of major genes in the NF-κB/NLRP3 signaling pathway. Additionally, tyrosine hydroxylase (TH) expression downregulation was rescued in the LPS + TP-5 group compared with the LPS group. We conclude that TP-5 exerts neuroprotection by alleviating LPS-induced inflammatory damage and dopaminergic neurodegeneration. The protective effect of TP-5 may involve the NF-κB/NLRP3 signaling pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-kappa BSignal TransductionThymopentinAnimalsMiceCell LineDopaminergic NeuronsInflammationLipopolysaccharidesMicrogliaNeuroinflammatory DiseasesNLR Family, Pyrin Domain-Containing 3 Protein

Stichwörter der Autor:innen

NF-κBNLRP3Neurodegenerative diseaseNeuroinflammationthymopentin (TP-5)

Substanzen

LipopolysaccharidesNF-kappa BNLR Family, Pyrin Domain-Containing 3 ProteinNlrp3 protein, mouseThymopentin

Autor:innen und Institutionen

  • Department of Neurology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, PR China.
  • Shanghai Geriatric Institute of Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200031, China. Electronic address: liute1979@shutcm.edu.cn.
  • Department of Neurology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, PR China. Electronic address: yunchw@medmail.com.cn.

Förderung

  • National Natural Science Foundation of China
  • Ministry of Science and Technology of the People's Republic of China

Zitieren

APA

Peng, S. J., Feng, Y., Li, X., Wang, X. X., Wang, Y., Zhou, B. T., Liu, Y., Liu, T., & Wu, Y. C. (2023). Thymopentin (TP-5) prevents lipopolysaccharide-induced neuroinflammation and dopaminergic neuron injury by inhibiting the NF-κB/NLRP3 signaling pathway. International Immunopharmacology, 119, 110109. https://doi.org/10.1016/j.intimp.2023.110109

Vancouver

Peng SJ, Feng Y, Li X, Wang XX, Wang Y, Zhou BT, et al. Thymopentin (TP-5) prevents lipopolysaccharide-induced neuroinflammation and dopaminergic neuron injury by inhibiting the NF-κB/NLRP3 signaling pathway. International Immunopharmacology. 2023;119:110109. doi:10.1016/j.intimp.2023.110109

BibTeX
@article{Peng2023,
  author = {Peng, Si-Jia and Feng, Ya and Li, Xuan and Wang, Xi-Xi and Wang, Yu and Zhou, Bu-Tian and Liu, Ye and Liu, Te and Wu, Yun-Cheng},
  title = {Thymopentin (TP-5) prevents lipopolysaccharide-induced neuroinflammation and dopaminergic neuron injury by inhibiting the NF-κB/NLRP3 signaling pathway},
  journal = {International Immunopharmacology},
  year = {2023},
  volume = {119},
  pages = {110109},
  doi = {10.1016/j.intimp.2023.110109}
}
Kostenlos starten →